1. Home
  2. XPOF vs XFOR Comparison

XPOF vs XFOR Comparison

Compare XPOF & XFOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Xponential Fitness Inc.

XPOF

Xponential Fitness Inc.

HOLD

Current Price

$5.74

Market Cap

289.4M

ML Signal

HOLD

Logo X4 Pharmaceuticals Inc.

XFOR

X4 Pharmaceuticals Inc.

HOLD

Current Price

$3.73

Market Cap

407.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
XPOF
XFOR
Founded
2017
2014
Country
United States
United States
Employees
N/A
143
Industry
Services-Misc. Amusement & Recreation
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
289.4M
407.5M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
XPOF
XFOR
Price
$5.74
$3.73
Analyst Decision
Buy
Strong Buy
Analyst Count
9
5
Target Price
$10.06
$25.20
AVG Volume (30 Days)
852.8K
584.9K
Earning Date
06-08-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
35.24
N/A
EPS
N/A
N/A
Revenue
$11,092,000.00
N/A
Revenue This Year
N/A
$1,263.94
Revenue Next Year
$5.57
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.83
$0.17
52 Week High
$11.14
$6.63

Technical Indicators

Market Signals
Indicator
XPOF
XFOR
Relative Strength Index (RSI) 38.78 50.36
Support Level $5.65 $3.38
Resistance Level $8.90 $4.16
Average True Range (ATR) 0.65 0.27
MACD -0.03 0.07
Stochastic Oscillator 40.77 33.43

Price Performance

Historical Comparison
XPOF
XFOR

About XPOF Xponential Fitness Inc.

Xponential Fitness Inc is a curator of boutique fitness brands. Its diversified portfolio of brands includes Club Pilates, a Pilates brand in the United States; CycleBar, an indoor cycling brand in the United States; StretchLab, a concept offering one-on-one and group stretching services; Row House, a high-energy, low-impact indoor rowing workout; AKT, a dance-based cardio workout combining toning, interval and circuit training; YogaSix a franchised yoga brand; Pure Barre, a total body workout that uses the ballet barre to perform small isometric movements; Stride, a treadmill-based cardio and strength training concept; Rumble, a boxing-inspired full-body workout; and BFT, a functional training and strength-based program. Its key revenue source is franchise income.

About XFOR X4 Pharmaceuticals Inc.

X4 Pharmaceuticals Inc is a biopharmaceutical company developing and commercializing novel therapeutics for the treatment of rare diseases of the immune system. The Company's lead clinical candidate is mavorixafor, a small molecule antagonist of the chemokine receptor CXCR4 that is being developed as an oral, once-daily therapy. It can increase the mobilization of mature, functional white blood cells from the bone marrow into the bloodstream. It also has two pre-clinical candidates X4P-003 and X4P-002 which are CXCR4 antagonists with different properties.

Share on Social Networks: